Reversal of Multidrug Resistance by New Dihydropyridines with Low Calcium Antagonist Activity

References

• Gottesman M M. How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1993; 53: 747–54
   PubMed Web of Science ®Google Scholar
• Stewart D J, Evans W K. Non-chemotherapeutic agents that potentiate chemotherapy efficacy. Cancer Treat Rev 1989; 16: 1–40
   PubMed Web of Science ®Google Scholar
• Kiue A, Sano T, Suzuki K, et al. Activities of newly synthesized dihydropyridines in overcoming of vincristine resistance. calcium antagonism, and inhibition of photoaffinity labeling of P-glycoprotein in rodents. Cancer Res 1990; 50: 310–7
   PubMed Web of Science ®Google Scholar
• Yoshinari T, Iwasawa Y, Miura K, et al. Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activity. Cancer Chemother Pharmacol 1989; 24: 367–70
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Takano H, Kiue A, Kohno K, Kuwano M. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistanl and atypical multidrug-resistant human cancer cells. Anticancer Drug Des 1991; 6: 47–57
   PubMedGoogle Scholar
• Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y. Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Res 1983; 43: 2267–72
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 1982; 42: 4730–3
   PubMed Web of Science ®Google Scholar
• Keller R P, Altermatt H J, Nooter K, et al. SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia. Int J Cancer 1992; 50: 593–7
   PubMed Web of Science ®Google Scholar
• Cairo M S, Siegel S, Anas N, Sender L. Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors. Cancer Res 1989; 49: 1063–6
   PubMed Web of Science ®Google Scholar
• Cozzi P, Meninchincheri M, Capolongo L, Mongelli N. European Patent Appl. 0533504 A1, 1992
   Google Scholar
• Johnson R K, Chitnis M P, Embrey W M, Gregory E B. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treat Rep 1978; 62: 1535–47
   PubMedGoogle Scholar
• Grandi M, Geroni C, Giuliani F C. Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin. Short communication. Br J Cancer 1986; 54: 515–8
   PubMed Web of Science ®Google Scholar
• Triggle D J, Langs D A, Janis R A. Calcium channel ligands: structure-function relationship of the 1,4 dihydropyridines. Med Res Rev 1989; 9: 123–80
   PubMed Web of Science ®Google Scholar
• Cozzi P, Carganico G, Fusar D, et al. Imidazol-1-yl and pyridin-3-yl derivatives of 4-phenyl-1,4-dihydropyridines combining Ca++ antagonism and thromboxane A, synthase inhibition. J Med Chem 1993; 36: 2964–72
   PubMed Web of Science ®Google Scholar
• Niwa K, Yamada K, Furukawa T, et al. Effect of a dihydropyridine analogue. 2-[benzyl (phenyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo-1,3, 2-dioxaphos-phorinan-2-yl)-1-(2-morpholino-cthyl)-4-(3-nitrophenyl)-3-pyridinecarboxylate on reversing in vivo resistance of tumor cells to adriamycin. Cancer Res 1992; 52: 3655–60
   PubMed Web of Science ®Google Scholar
• Shinoda H, Inaba M, Tsuruo T. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52. Cancer Res 1989; 49: 1722–6
   PubMed Web of Science ®Google Scholar
• Kiue A, Sano T, Naito A, et al. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro. Jpn J Cancer Res 1990; 1: 1057–64
   Google Scholar
• Nogae I, Kohno K, Kikuchi J, et al. Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein. Biochem Pharmac 1989; 38: 519–27
   PubMed Web of Science ®Google Scholar